Navigation Links
Ennis & Ennis, P.A. Announces Nationwide Free Legal Consultations For Users of Paxil
Date:12/16/2009

Ennis & Ennis, P.A. will continue to offer free nationwide confidential legal consultations for users of Paxil who have suffered from serious Paxil side effects such as: Birth Defects, Attempted Suicide, Suicide and Addiction Issues. Individuals suffering from Paxil side effects can call toll free at 1-800-856-6405 or go to the firm’s website at http://www.ennislaw.com and fill out an online case evaluation form.

(PRWEB) December 16, 2009 -- Bloomberg news reported yesterday that GlaxoSmithKline, the manufacturer of Paxil has paid almost $1 billion to resolve lawsuits over Paxil since it came on the market in 1993. GlaxoSmithKline, the largest U.K. drug maker has paid approximately $390 million for suicides and attempted suicides and another $200 million for birth defect and Addiction cases.

Ennis & Ennis, P.A. will continue to investigate and offer free nationwide consultations for users of Paxil who have committed Suicide, Attempted Suicide, Addiction issues and women who have taken Paxil during the first trimester of pregnancy who have given birth to children with Birth Defects. Paxil users can call the firms toll free number at 1-800-856-6405 or go to the Paxil website at http://www.paxilside-effects.com. Any users who have suffered these side effects are advised to go to http://www.fda.gov and fill out a MedWatch form. Attorney David Ennis does not recommend discontinuing use of Paxil unless first consulting with your physician.

Paxil was first introduced into the market in 1993. It is an antidepressant commonly used for the treatment of depression and anxiety. In 2005 the FDA issued a public advisory letter (http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2005/ucm108527.htm) warning that Paxil showed an increased risk of birth defects, in particular heart defects, in newborns where their mothers took Paxil during the first trimester of pregnancy. Some of these defects include Septal defects-including Atrial and Ventricular. On top of the risk of Septal defects is the risk of persistent hypertension . A study published in the New England Journal of Medicine (http://content.nejm.org/cgi/content/full/354/6/579) concluded that the rate of PPHN in babies whose mother used an SSRI, like Paxil was six fold over those babies whose mothers did not take an antidepressant.

Attorney David Ennis states, "We have been investigating Paxil cases nationwide since 2006. We are fearful many mothers do not realize they have given birth to children who have life threatening birth defects and it is related to their use of Paxil during pregnancy. Many states statute of limitations have not run yet on these claims due to the fact in many states the statute does not start until the minor reaches 18 years of age".

On October 13, 2009 a Philadelphia jury (Kilker vs. GlaxoSmithKline Philadelphia Court of Common Pleas case no. 001813) found the drugmaker should pay $2.5 million to a family of a 3 year old boy born with a heart defect after his mother took Paxil while pregnant.

If you or a loved one has been injured as a result of Paxil side effects such as birth defects, suicide or addiction you may be entitled to compensation. Contact the Paxil Birth Defects Lawyers of Ennis & Ennis, P.A. today for a free, confidential, case evaluation by visiting the website http://www.paxilside-effects.com or calling toll-free 1-800-856-6405.

About Ennis & Ennis, P.A. Lawyers:
Ennis & Ennis, P.A. is a national mass tort law firm with offices in Fort Lauderdale, Fl., Miami, Fl. and Washington, D.C, The lawyers at Ennis & Ennis have recovered over $100 million in a wide range of mass tort and personal injury settlements including: Vioxx, Zyprexa, Tequin, ReNu, Medtronic Pacemakers and Defibrillators, Guidant Pacemakers and Defibrillators, Celebrex, Bextra, Stevens Johnson Syndrome related cases, Ortho Evra Birth Control Patch and others. The firm is currently investigating claims related to: Yaz Side Effects, Yasmin, Ocella, Accutane, Avandia, Fosamax, Reglan, Paxil, Plavix, Zimmer, Stryker, Smith & Nephew and Ethex. To find out more you can go to http://www.ennislaw.com or call our toll free number at 1-800-856-6405.

Ennis & Ennis has been handling individual lawsuits since 1986.
Remember: The law limits your time to file a lawsuit. Don't lose your rights by waiting too long to explore your legal options.

###

Read the full story at http://www.prweb.com/releases/Paxil-Birth-Defects/Paxil-Side-Effects/prweb3345644.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. TIGroup Names Dennis M. Smith as Chief Financial Officer
2. Kendle Executive Dennis Hurley, DrSc to Present Keynote Address at DIA Latin American Congress 2007
3. American Airlines 13th Annual Celebrity Golf and Tennis Weekend Will Raise Funds to Fight Breast Cancer
4. Bacchus Vascular Names Dennis Rosenberg as Vice President of Marketing
5. The Justin Gimelstob Childrens Fund Hosts Tennis Exhibition
6. Dennis Joyce Joins Executive and Board Search Firm Hodge / Niederer / Cariani / Lindsay
7. Superstar John McEnroe to Highlight The Kennedy Funding Invitational Tennis Tournament, July 9-13, 2008
8. Dr. Dennis Fenton and Dr. Steve Kaldor Join Amira Board of Directors
9. Wheelchair Tennis Tournament Draws Athletes Throughout California
10. Ferring Pharmaceuticals EUFLEXXA(R) to Serve as a Sponsor for the Babolat World Tennis Classic
11. North Castle Partners Names Dennis Lee of Octane Fitness CEO of the Year
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Ennis & Ennis, P.A. Announces Nationwide Free Legal Consultations For Users of Paxil
(Date:2/8/2016)... PISCATAWAY, N.J. (PRWEB) , ... February 08, 2016 ... ... of protective footwear and clothing, announced expansion into Canada to provide its range ... has opened a sales office in Quebec City that will provide bilingual customer ...
(Date:2/8/2016)... GA (PRWEB) , ... February ... ... technology and security executive networking and relationship-marketing firm, announced today that nominations ... 2016 Information Security Executive® (ISE®) West Awards. , Awards include the ...
(Date:2/8/2016)... ... 2016 , ... GrassrootsHealth published data from its D*action public ... in the GrassrootsHealth cohort with substantially higher vitamin D levels than a cohort ... states Carole Baggerly, Director of GrassrootsHealth, “the safety and benefits of vitamin ...
(Date:2/8/2016)... (PRWEB) , ... February 08, 2016 , ... The ... annually in this country. The AutismOne 2016 Conference, which is being held May 25-29 ... often won’t hear elsewhere about helpful interventions and causes of chronic illness in children. ...
(Date:2/7/2016)... ... February 07, 2016 , ... Dr. Todd ... to his medical and surgical expertise. Technically known as deoxycholic acid or previously ... as a non-surgical alternative for reduction of fat below the chin (aka the ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... -- http://www.researchandmarkets.com/research/x6mkjm/knee ) has announced the ... by Product Type (Primary (Cemented & Cementless), Partial, ... Japan, Bric, Turkey, Indonesia - Global Analysis and ... --> http://www.researchandmarkets.com/research/x6mkjm/knee ) has announced ... Market by Product Type (Primary (Cemented & Cementless), ...
(Date:2/8/2016)...  Avista Pharma Solutions ("Avista Pharma") announced today that ... Officer (CFO). Mr. Setzer is a finance and operations ... roles within growing technology and life science companies. Prior ... Director of Finance at INC Research, a publicly traded ... . Previously, Mr. Setzer served as CFO of Expression ...
(Date:2/8/2016)... Therapeutics, Inc. announced today that the United States Patent and ... the use of NephroFlow to treat acute kidney injury (AKI). ... "We are pleased to secure our rights to such a ... HemaFlo,s founder, said, "We are pleased to secure our rights ... Dale Peterson , PhD, HemaFlo,s founder, said, "We are pleased ...
Breaking Medicine Technology: